Crispr Therapeutics Secures $25 Million in Series A Financing

The funding and the team's collective expertise will allow CRISPR Therapeutics to translate its technology into important new gene medicines that have the potential to cure serious genetic diseases at the molecular level.

http://ift.tt/1pJcJ9C